News
Preliminary trial findings suggest transdermal cannabis may help ease pruritus-related itching in patients undergoing hemodialysis. Cannabis cream relieved itching symptoms over the short-term in a ...
Cannabis cream relieved itching symptoms over the short-term in a small trial of patients on hemodialysis experiencing uremic pruritus.
A topical cream containing cannabis “significantly reduced the severity of itching” symptoms in patients with chronic kidney disease-related pruritus, according to published data.Many ...
Xueqian Zhao Haipeng Sun Wei Li * Department of Nephrology, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China Aim: This network meta-analysis was to analyze and rank the ...
MC2 Therapeutics today announced it has completed enrollment in its European Phase 2 trial assessing the safety and efficacy of MC2-25 CKD, an innovative new drug candidate for the treatment of urea ...
In addition, the Company has initiated a Phase 2/3 program of oral difelikefalin for the treatment of moderate-to-severe pruritus in patients with notalgia paresthetica.
--Cara Therapeutics, Inc., a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that its ...
About Cara Therapeutics Cara Therapeutics is a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results